Arch Fam Med
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 2 No. 10, October 1993 TABLE OF CONTENTS
  •  Online Features
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Are Anorectic Agents the 'Magic Bullet' for Obesity?

Susan Zelitch Yanovski, MD

Arch Fam Med. 1993;2(10):1025-1027.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Stunkard AJ. The management of obesity. N Y State J Med. 1958;58:79-87. PUBMED
2. Hearings Before the Subcommittee on Regulation, Business Opportunities, and Energy of the House Committee on Small Business. (Testimony of Janet D. Steiger, Chairman, Federal Trade Commission, March 26, 1990.)
3. Levy AS, Heaton AW. Weight control practices of US adults trying to lose weight. Ann Intern Med. 1993;119:661-666. FREE FULL TEXT
4. Serdula M. Weight control practices of US adolescents and adults. Ann Intern Med. 1993;119:667-671. FREE FULL TEXT
5. Brownell KD, Kramer FM. Behavioral management of obesity. Med Clin North Am. 1989;73:185-201. PUBMED
6. Stunkard AJ, McLaren-Hume M. The results of treatment for obesity. Arch Intern Med. 1959;103:79-85. FREE FULL TEXT
7. Wadden TA, Bartlett SJ. Very low calorie diets: an overview and appraisal. In: Wadden TA, Vanltallie TB, eds. Treatment of the Seriously Obese Patient. New York, NY: Guilford Press; 1992:44-79.
8. Bray GA. Drug treatment of obesity. Am J Clin Nutr. 1992;55(suppl):538-544.
9. Stahl KA, Imperiale TF. An overview of the efficacy and safety of fenfluramine and mazindol in the treatment of obesity. Arch Fam Med. 1993;2:1033-1038. FREE FULL TEXT
10. Atkinson RL, Hubbard VS. Report on NIH Workshop on Pharmacologic Treatment of Obesity. Am J Clin Nutr. In press.
11. Weintraub M. Long-term weight control: the National Heart, Lung, and Blood Institute funded multi-modal intervention study. Clin Pharmacol Ther. 1992;51:581-585. PUBMED
12. Weintraub M, Sundaresan PR, Madan M, et al. Long-term weight control study I (weeks 0-34): the enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Clin Pharmacol Ther. 1992;51:586-594. PUBMED
13. Weintraub M, Sundaresan PR, Schuster B, et al. Long-term weight control study II (weeks 34-104): an open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise. Clin Pharmacol Ther. 1992;51:595-601. PUBMED
14. Weintraub M, Sundaresan PR, Schuster B, Moscucci M, Stein EC. Long-term weight control study III (weeks 104-156): an open-label study of dose adjustment of fenfluramine and phentermine. Clin Pharmacol Ther. 1992;51:602-607. PUBMED
15. Weintraub M, Sundaresan PR, Schuster B, et al. Long-term weight control study IV (weeks 156-190): the second double-blind phase. Clin Pharmacol Ther. 1992;51:608-614. PUBMED
16. Weintraub M, Sundaresan PR, Schuster B, Averbuch M, Stein EC, Byrne L. Long-term weight control study V (weeks 190-210): follow-up of participants after cessation of medication. Clin Pharmacol Ther. 1992;51:615-618. PUBMED
17. Weintraub M, Sundaresan PR, Cox C. Long-term weight control study VI: individual participant response patterns. Clin Pharmacol Ther. 1992;51:619-633. PUBMED
18. Weintraub M, Sundaresan PR, Schuster B. Long-term weight control study VII (weeks 0-210): serum lipid changes. Clin Pharmacol Ther. 1992;51:634-641. PUBMED
19. Weintraub M. Long-term weight control study: conclusions. Clin Pharmacol Ther. 1992;51:642-646. PUBMED
20. Guy-Grand B. Clinical studies with dexfenfluramine. Am J Clin Nutr. 1992;55:173-175.
21. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet. 1989;2:1142-1145. PUBMED
22. Stallone DD, Stunkard AJ. Long-term use of appetite suppressant medication: rationale and recommendations. Drug Dev Res. 1992;26:1-20. PUBMED
23. Stunkard AJ, Craighead LW, O'Brian R. Controlled trial of behavioral modification, pharmacotherapy, and their combination in the treatment of obesity. Lancet. 1980;2:1045-1047. PUBMED
24. Craighead LW. Sequencing of behavior therapy and pharmacotherapy for obesity. J Consult Clin Psychol. 1984;52:190-199. PUBMED
25. Rodin J, Elias M, Silberstein LR, Wagner A. Combined behavioral and pharmacologic treatment for obesity: predictors of successful weight maintenance. J Consult Clin Psychol. 1988;56:399-404. PUBMED